Effectiveness of BNT162b2 and ChAdOx1 against SARS-CoV-2 household transmission: a prospective cohort study in England [version 2; peer review: 2 approved]

Effectiveness of BNT162b2 and ChAdOx1 against SARS-CoV-2 household transmission: a prospective cohort study in England [version 2; peer review: 2 approved]

Background The ability of SARS-CoV-2 vaccines to protect against infection and onward transmission determines whether immunisation can control global circulation. We estimated the effectiveness of Pfizer-BioNTech mRNA vaccine (BNT162b2) and Oxford AstraZeneca adenovirus vector vaccine (ChAdOx1) vacc...

Full description

Bibliographic Details
Main Authors: Elizabeth Miller, Nick Andrews, Jada Hackman, Stefan Flasche, Pauline Waight, Charlotte M. Gower, Stephane Hué, Catriona Skarnes, Freja CM Kirsebom, Jamie Lopez Bernal, Samuel Clifford, Louise Letley
Format: Article
Language:English
Published: Wellcome 2023-11-01
Series:Wellcome Open Research
Subjects:
covid
vaccination
secondary attack rate
SARS-CoV-2
household transmission
eng
Online Access:https://wellcomeopenresearch.org/articles/8-96/v2

Internet

https://wellcomeopenresearch.org/articles/8-96/v2

Similar Items